AusCann on fire
Seite 8 von 10 Neuester Beitrag: 20.10.24 15:59 | ||||
| Eröffnet am: | 27.03.17 13:27 | von: cannabistrad. | Anzahl Beiträge: | 228 |
| Neuester Beitrag: | 20.10.24 15:59 | von: honzi | Leser gesamt: | 97.249 |
| Forum: | Hot-Stocks | Leser heute: | 7 | |
| Bewertet mit: |  | |||
| Seite: < 1 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | | 9 | ... > | ||||
Optionen
| Boardmail an "Scratchi" |
Wertpapier: Auscann Group Holdings |
Optionen
| Boardmail an "Scratchi" |
Wertpapier: Auscann Group Holdings |
Canopy Growth launches Spectrum Australia with support from the Victoria State Government
Canada NewsWire
SMITHS FALLS, ON and MELBOURNE, Australia, April 25, 2018
SMITHS FALLS, ON and MELBOURNE, Australia, April 25, 2018 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or the "Company") is pleased to join the Victoria State Government in announcing the launch of the newest member of the Canopy Growth family, Spectrum Cannabis Australia ("Spectrum" or "Spectrum Australia").
image: https://mma.prnewswire.com/media/...owth_launches_Spectrum_Austra.jpg
[IMG]
Minister for Agriculture, the Hon. Jaala Pulford, alongside Ben Quirin, Managing Director of Spectrum Australia, announced the Company will invest up to $16 million AUD (~$16 million CAD) in the State of Victoria over the next four years to establish Spectrum's Asia-Pacific (APAC) headquarters and research and development facility.
"The State Government of Victoria has been an outstanding partner and welcomed our investment in the region with a shared passion for innovation in the medical cannabis industry," said Ben Quirin, Managing Director, Spectrum Australia. "Victoria is now home for Spectrum as we introduce our world renowned medical cannabis products to the State, across Australia, and throughout the entire APAC region as jurisdictions establish legal, regulated medical cannabis regimes."
The Victoria facility will enable domestic cultivation and production of high quality medical cannabis for patients while serving as a distribution hub for other jurisdictions in APAC. It will also operate as the APAC Research and Development Center for the Company, supporting the ongoing research collaboration between Spectrum Australia and Agriculture Victoria on innovations in medical cannabis cultivation and production.
"Collaborating with international experts on cultivation and manufacturing will build Victoria's capacity to develop our medicinal cannabis industry to be able to supply reliable and high quality medicinal cannabis products," said Minister for Agriculture, the Hon. Jaala Pulford.
The launch of Spectrum Australia builds on Canopy Growth's leadership position in the global medical cannabis space. Spectrum Australia's priority is to improve the lives of patients. This goal will be accomplished by focusing on three core areas:
Ensuring an affordable and consistent supply of medical cannabis is available to patients in Australia
Building production and research infrastructure in Australia
Engaging in rigorous evidence-based physician and pharmacist education to ensure patients' access needs are met
This week Canopy Growth renewed its commitment to Australian partner, AusCann (ASX:AC8). Together with the State Government of Victoria and our strong local partner Spectrum Australia is committed to building an industry for the benefit of patients and healthcare professionals throughout APAC.
Spectrum Cannabis - Medical Cannabis. Simplified.
Learn more by visiting spectrumcannabis.com.au
About Spectrum Cannabis
Spectrum is an international cannabis business dedicated to improving the lives of patients and increasing cannabinoid knowledge within physician communities around the world. Its colour-coded strain classification system is available in Canada with operations underway in the European Union and South America, and Australia. Spectrum products are available in a range of potencies and formats designed to simplify the dialogue around strength and dosage by categorizing medical cannabis according to THC and CBD levels. Spektrum Germany Gmbh processes cannabis for sale in Germany in a GMP-certified facility and then distributes products to hundreds of German pharmacies. Spectrum Denmark is a partnership between Canopy Growth and Danish Cannabis. Through the partnership, Spectrum Denmark is developing a large-scale greenhouse facility in the city of Odense. Learn more at www.spectrumcannabis.com.au
About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.
https://web.tmxmoney.com/...ewsid=7989248074343320&qm_symbol=WEED
https://www.wallstreet-online.de/diskussion/...61-370/auscann-on-fire
warum gibt der Kurs so nach ?!
sind LV's am Werk ?! Übernahme ?!
..aus der PDF sieht sieht man nur, das alles läuft
https://www.asx.com.au/asxpdf/20180607/pdf/43vlxvz1ltfywg.pdf
ASX: AC8
1,26 AUD +0,17 (16,20 %)
der Boden war erreicht , jetzt können die Großen wieder einsteigen (u.a. die Kleinen !)
https://translate.google.de/...t-101285%2F&edit-text=&act=url
erklärt wohl auch den Absturz
http://clients3.weblink.com.au/pdf/AC8/02052692.pdf
..das Warten hat ein Ende. Das Unternehmen ist gut positioniert !
> auscann on fire !
die Amis sind schon gut am kaufen..
heute > Nasdaq OTC + 8,90 %
z.Z. "noch" gute Nachkaufkurse, wers noch nicht so erkannt hat...
"AusCann ist ein Flagschiff mit über 180 Millionen Wert und 40 Millionen Cash auf dem Konto"
Der global player "Canopy Growth." ist mit an Bord.
https://translate.google.de/...2Finternational-footprint%2Fauscann%2F
.. ! Ende des Jahres sind wohl um die 0,90-1,00 Australische Dollar drin aber, wir müssen damit leben: "der News Flow ist immer sehr dünn, leider .
! Dank an nebenan > https://www.wallstreet-online.de/diskussion/1283140-41-50/auscann
Jetzt ist das Ding ja fast krepiert.
Optionen
| Boardmail an "Scratchi" |
Wertpapier: Auscann Group Holdings |
der Vorstand kauft jetzt auch und zwar für 58.000 $ Aktien. Nachdem der Kurs lange lange
runter geprügelt wurde ! also nichts mit krepieren ...
https://www.finanznachrichten.de/...en/auscann-group-holdings-ltd.htm
zZ 13 % +
..lege jetzt Mo. doch nochmal etwas Taschengeld nach. Das wird schon.
https://www.google.com/...d=0ahUKEwj7paTusbfhAhUP2aYKHQxFAr0Q_AUIDigA
https://www.wallstreet-online.de/diskussion/...uscann#neuster_beitrag
https://translate.google.de/...der-lifts-interest-to-1328-221926.html
https://www.finanznachrichten.de/...en/auscann-group-holdings-ltd.htm
https://www.9news.com.au/national/...221d-914d-4e54-8225-42e545815785
https://translate.google.de/...stown-for-the-2019-bioshares-summit%2F
- es geht voran !
Quartalsberichte etc....
https://www.finanznachrichten.de/...en/auscann-group-holdings-ltd.htm
https://www.asx.com.au/asxpdf/20191029/pdf/449zf1plqjv8m1.pdf
Canopy Growth hat leider, wie man sich denken kann, wohl eigene finanzielle Baustellen. Sie haben ihren Anteil herausgezogen, die Forschungs- und Zusammenarbeit läuft aber nach wie vor.
AusCann Effects Board Changes
4 November 2019 – Leading medical cannabis company AusCann Group Holdings
Limited (ASX:AC8) (AusCann or ‘the Company’) announces that further to the Board
renewal process announced on 28 October 2019, the Company has appointed Mr Christopher
Mews as a Non-Executive Director of AusCann. Mr Mews is the nominee from AusCann’s
largest shareholder, Merchant Funds Management, with his appointment to be effective from
1 December 2019.
Mr Mews is an experienced non-executive director with over 20 years in the financial services
sector, having held senior positions in finance, corporate secretarial and compliance in listed
and unlisted companies.
Mr Mews is currently the Chief Financial Officer and Company Secretary of Merchant Group
Pty Ltd, a Perth based financial services firm that provides funds management and corporate
finance services, with investment experience both in Australia and internationally in the
medical cannabis sector. Prior to Merchant Group, he was the Chief Financial Officer and
Company Secretary of listed biotech Company Polynovo Limited (ASX:PNV), and is currently
Company Secretary and Non-Executive Director of VPCL Limited (ASX:VPC).
Mr Mews holds a Bachelor of Business majoring in Accounting and is a Certified Practising
Accountant, a Chartered Company Secretary and member of the Governance Institute of
Australia.
The Company also advises that Dr Paul MacLeman has resigned as an Executive Director of
AusCann effective today. Dr MacLeman joined the AusCann Board as a part of the CEO
leadership transition in late 2018, and with that transition to the Company’s new CEO Mr
Ido Kanyon having now taken place, it is appropriate for him to step down. The Board thanks
Dr MacLeman for standing in as interim CEO and Director during this important transition
period.
ENDS